Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 12/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14520354 | 0.96 | SOAT1 (0.69) | SOAT1 | |
| SCHEMBL5470497 | 0.88 | SOAT1 (0.73) | SOAT1 | |
| SCHEMBL14520396 | 0.88 | SOAT1 (0.65) | SOAT1 | |
| SCHEMBL14520394 | 0.88 | SOAT1 (0.70) | SOAT1 | |
| SCHEMBL5475890 | 0.86 | SOAT1 (0.70) | SOAT1 | |
| SCHEMBL14520376 | 0.85 | SOAT1 (0.59) | SOAT1 | |
| SCHEMBL5478376 | 0.83 | SOAT1 (0.69) | SOAT1 | |
| SCHEMBL14520346 | 0.83 | SOAT1 (0.75) | SOAT1 | |
| SCHEMBL14520373 | 0.83 | SOAT1 (0.59) | SOAT1 | |
| SCHEMBL14520395 | 0.82 | SOAT1 (0.59) | SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078120-A1 | Novel piperidine derivative | LDLR, PRMT5, MSR1 | SOAT1 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.